tirzepatide summit trial Effects of on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the 408. Journal Club: The SUMMIT
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Live Spec
408. Journal Club: The SUMMIT Trial with Dr. Milton Packer 60 Second Journal Club: The SUMMIT trial examined cardiovascular outcomes of treatment with tirzepatide in patients with heart failure with preserved ejection fraction and obesity. Read the full trial How the weight loss drug tirzepatide is also helping heart failure patients Tirzepatide Improves HFpEF Symptoms and Outcomes Cardiac Wire Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity: @NEJM The SUMMIT trial @AHAScience Summary
Store: capewinelands.gov.za · Domain: capewinelands.gov.za





















